Users fear that lymphoma drugs will disappear.
Garber
Ken
K
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D011307:Drug Prescriptions; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000532:radiotherapy; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy; D015203:Reproducibility of Results
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C422802:ibritumomab tiuxetan; C119496:tositumomab I-131